Information  X 
Enter a valid email address

GlaxoSmithKline PLC (GSK)

  Print      Mail a friend       Annual reports

Wednesday 02 April, 2014

GlaxoSmithKline PLC

Director/PDMR Shareholding

RNS Number : 8562D
GlaxoSmithKline PLC
02 April 2014
 



 Notification of Transactions of Directors, Persons Discharging Managerial Responsibility or Connected Persons

 

I give below details of changes in the Directors' interests in the Ordinary Shares and American Depositary Shares (ADSs) of GlaxoSmithKline plc.

 

On 31 March 2014, the Company's Non-Executive Directors were allocated notional Ordinary Shares at a price of £16.08 per Ordinary Share, and notional ADSs at a price of $53.75 per ADS under the share allocation arrangements for Non-Executive Directors for the period of service from 1 January 2014 to 31 March 2014:

 

Non Executive Director

Ordinary Shares

American Depositary Shares (ADSs)




Sir Christopher Gent

3,886.816





Professor Sir Roy Anderson

563.588





Dr Stephanie Burns

                

433.042




Stacey Cartwright

446.984





Lynn  Elsenhans


779.475




Judy Lewent


367.144




Sir Deryck Maughan


1,092.019




Dr Daniel Podolsky


819.014




Tom de Swaan

408.116





Jing Ulrich


216.521




Hans Wijers

446.984





Sir Robert Wilson

446.984





 

The Company and the Non-Executive Directors were informed of these allocations on 1 April 2014.

 

This notification relates to transactions notified in accordance with Disclosure and Transparency Rule 3.1.4R(1)(a).

 

 

V A Whyte

Company Secretary

2 April 2014

 


This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDSKLLBBZZFZBBK

a d v e r t i s e m e n t